HomeProduct Complimentary download Plant Health Care signs development and distribution agreement with Arysta LifeScience

Plant Health Care signs development and distribution agreement with Arysta LifeScience

Keyword:
Publish time: 5th December, 2014      Source: December 5, 2014Plant Health Care (AIM: PHC.L), a leading provider of novel biological products to
Information collection and data processing:  CCM     For more information, please contact us
Plant Health Care signs development and distribution agreement with Arysta LifeSciencePlant Health Care signs development and distribution agreement with Arysta LifeScience" title="Share this link on Facebook">December 5, 2014Plant Health Care (AIM: PHC.L), a leading provider of novel biological products toglobal agriculture markets, announces that it has signed a development &distribution agreement with Arysta LifeScience Limited for the use of Plant HealthCare’s proprietary protein technology for foliar application to sugar cane in Brazil.Commercial terms were not disclosed.Under this agreement, Arysta LifeScience will evaluate the technology across arange of geographical locations throughout Brazil. The expanded testing program willgenerate detailed information on increased biomass and sucrose production, whichin earlier studies showed significant and reliable increases in yield.Pending local registration and consistent, reliable test results in the evaluationprogram, first sales of the product are anticipated in the 2017 crop season.Sugarcane is an important crop in Brazil, covering more than 8,000,000 hectares.Much of this cane is used for ethanol production, which is a major pillar in therenewable fuel policy of the Brazilian government.“We are pleased to enter into this agreement with Arysta LifeScience to bring thisproprietary protein technology to such a commercially significant crop in Brazil,” saidPaul Schmidt, CEO of Plant Health Care. “This is another step forward in theimplementation of Plant Health Care’s dual-track strategy of substantially growingrevenue from existing products whilst pursuing an aggressive R&D focus on newtechnology development.”“We are excited about the opportunity to expand the organization’s portfolio insugarcane,” added Paula Pinto, Global Head of Marketing at Arysta LifeScience.“The addition of the proprietary protein technology will provide sugarcane farmersthe opportunity to significantly increase yield and sugar production in ratoon cane.”More news from:. Arysta LifeScience Corporation. Plant Health Care PlcWebsite: http://www.cnchemicals.com/: December 5, 2014The news item on this page is copyright by the organization where it originatedFair use notice